Registered substances

Data platform availability banner - registered substances

New Data Availability System

A new Data Availability System is being developed by ECHA. To begin with this system will take over the responsibility of making REACH registration data available, once it is ready. We expect the first version to be publicly available by the end of 2023.

Since ECHA aims to devote our maximum effort to this new system, we can no longer maintain REACH registration data on the current Dissemination Platform. As such once the IUCLID format change begins on 19th May 2023 we will no longer update REACH registered substance factsheets. The factsheets will remain online, but will not be updated.

New and updated REACH registration submissions, as well as all registrations on file, will be made available in the new system when it is ready. We will inform you of what you can expect in the new system, along with details of when and where to find it.

We appreciate your understanding in the meantime.

DISSEMINATION
PLATFORM

REACH - Registration, Evaluation, Authorisation and Restriction of Chemicals Regulation

Registered Substances Factsheets

Substances which have been registered and can be placed on the EEA market by those companies with a valid registration



No results were found
Details
Dexamethasone
200-003-9 50-02-2 Active Intermediate Joint Intermediate use only 25-01-2022 View substance registered dossier
Hydrocortisone 21-acetate
200-004-4 50-03-3 Active Intermediate Joint Intermediate use only 12-12-2012 View substance registered dossier
Cortisone 21-acetate
200-006-5 50-04-4 Active Intermediate Joint Intermediate use only 14-01-2022 View substance registered dossier
Phenobarbital
200-007-0 50-06-6 Active Intermediate Joint Intermediate use only 23-03-2018 View substance registered dossier
Lactic acid
200-018-0 50-21-5 Active Full Joint ≥ 100 to < 1 000 tonnes 04-01-2023 View substance registered dossier
Hydrocortisone
200-020-1 50-23-7 Active Intermediate Joint Intermediate use only 06-12-2022 View substance registered dossier
Prednisolone
200-021-7 50-24-8 Active Full Joint ≥ 10 to < 100 tonnes 04-05-2022 View substance registered dossier
Estradiol
200-023-8 50-28-2 Active Full Joint ≥ 1 to < 10 tonnes 10-11-2021 View substance registered dossier
2,3-dichlorobenzoic acid
200-039-5 50-45-3 Active Intermediate Joint Intermediate use only 17-04-2020 View substance registered dossier
Desipramine
200-040-0 50-47-5 Active Intermediate Joint Intermediate use only 08-02-2018 View substance registered dossier
Amitriptyline
200-041-6 50-48-6 Active Intermediate Joint Intermediate use only 11-10-2018 View substance registered dossier
Imipramine
200-042-1 50-49-7 Active Intermediate Joint Intermediate use only 08-03-2018 View substance registered dossier
Thioridazine
200-044-2 50-52-2 Active Intermediate Joint Intermediate use only 19-03-2018 View substance registered dossier
Chlorpromazine
200-045-8 50-53-3 Active Intermediate Joint Intermediate use only 16-05-2017 View substance registered dossier
D-ribose
200-059-4 50-69-1 Active Full Joint ≥ 0 to < 10 tonnes 03-05-2019 View substance registered dossier
D-ribose
200-059-4 50-69-1 Active Intermediate Joint Intermediate use only 15-09-2020 View substance registered dossier
O-acetylsalicylic acid
200-064-1 50-78-2 Active Full Joint ≥ 100 to < 1 000 tonnes 02-04-2013 View substance registered dossier
O-acetylsalicylic acid
200-064-1 50-78-2 Active Intermediate Individual Intermediate use only 27-03-2015 View substance registered dossier
2-hydroxy-p-toluic acid
200-068-3 50-85-1 No longer Valid Full Joint No longer valid 15-02-2018 View substance registered dossier
2-hydroxy-p-toluic acid
200-068-3 50-85-1 Active Intermediate Joint Intermediate use only 22-09-2021 View substance registered dossier
Thymidine
200-070-4 50-89-5 Active Full Joint ≥ 1 000 to < 10 000 tonnes 02-09-2014 View substance registered dossier
α-phenyl-1H-benzimidazole-2-methanol
200-073-0 50-97-5 Active Full Joint ≥ 1 to < 10 tonnes 14-10-2022 View substance registered dossier
Ephedrine hydrochloride
200-074-6 50-98-6 Active Intermediate Joint Intermediate use only 08-11-2018 View substance registered dossier
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
200-076-7 51-03-6 Active Full Joint ≥ 1 000 to < 10 000 tonnes 28-03-2022 View substance registered dossier
2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
200-076-7 51-03-6 No longer Valid Full Individual No longer valid 02-07-2013 View substance registered dossier
Procaine hydrochloride
200-077-2 51-05-8 Active Intermediate Joint Intermediate use only 02-07-2018 View substance registered dossier
Benzimidazole
200-081-4 51-17-2 Active Full Joint ≥ 10 to < 100 tonnes 09-12-2021 View substance registered dossier
Fluorouracil
200-085-6 51-21-8 Active Intermediate Joint Intermediate use only 29-05-2018 View substance registered dossier
2,4-dinitrophenol
200-087-7 51-28-5 Active Full Joint ≥ 100 to < 1 000 tonnes 09-03-2022 View substance registered dossier
Hyoscine
200-090-3 51-34-3 Active Full Joint ≥ 10 to < 100 tonnes 25-11-2021 View substance registered dossier
L-4-hydroxyproline
200-091-9 51-35-4 Active Full Joint ≥ 10 to < 100 tonnes 27-04-2022 View substance registered dossier
L-4-hydroxyproline
200-091-9 51-35-4 Active Intermediate Joint Intermediate use only 03-05-2018 View substance registered dossier
3,5-dichlorobenzoic acid
200-092-4 51-36-5 Active Intermediate Joint Intermediate use only 20-09-2019 View substance registered dossier
DL-thyroxin
200-101-1 51-48-9 Active Full Individual ≥ 1 to < 10 tonnes 10-09-2021 View substance registered dossier
Dexamphetamine
200-112-1 51-64-9 Active Intermediate Joint Intermediate use only 23-10-2018 View substance registered dossier
4-(2-aminoethyl)phenol
200-115-8 51-67-2 Active Intermediate Joint Intermediate use only 05-01-2016 View substance registered dossier
4-(2-aminoethyl)phenol
200-115-8 51-67-2 Cease Manufacture Full Joint Cease manufacture 06-03-2018 View substance registered dossier
N,N,N',N'-tetramethylmethylenediamine
200-124-7 51-80-9 Active Intermediate Joint Intermediate use only 29-10-2014 View substance registered dossier
Morphine hydrochloride
200-136-2 52-26-6 Active Intermediate Joint Intermediate use only 16-03-2017 View substance registered dossier
Bronopol
200-143-0 52-51-7 Active Full Joint ≥ 100 to < 1 000 tonnes 01-12-2022 View substance registered dossier
Cysteine hydrochloride
200-157-7 52-89-1 Active Full Joint ≥ 1 000 to < 10 000 tonnes 07-12-2022 View substance registered dossier
L-cysteine
200-158-2 52-90-4 Active Full Joint ≥ 10 to < 100 tonnes 10-11-2020 View substance registered dossier
L-cysteine
200-158-2 52-90-4 Active Intermediate Joint Intermediate use only 30-01-2019 View substance registered dossier
Estrone
200-164-5 53-16-7 Active Full Joint ≥ 10 to < 100 tonnes 24-08-2021 View substance registered dossier
Methylprednisolone 21-acetate
200-171-3 53-36-1 Active Intermediate Joint Intermediate use only 14-01-2022 View substance registered dossier
Prasterone
200-175-5 53-43-0 Active Intermediate Joint Intermediate use only 26-08-2022 View substance registered dossier
Nadide
200-184-4 53-84-9 Active Full Joint ≥ 1 to < 10 tonnes 11-03-2022 View substance registered dossier
Indometacin
200-186-5 53-86-1 Active Intermediate Joint Intermediate use only 28-03-2018 View substance registered dossier
Nicotine
200-193-3 54-11-5 Active Full Joint ≥ 1 000 to < 10 000 tonnes 04-04-2022 View substance registered dossier
Nicotine
200-193-3 54-11-5 Active Intermediate Individual Intermediate use only 14-04-2021 View substance registered dossier
Sodium salicylate
200-198-0 54-21-7 Active Full Joint ≥ 100 to < 1 000 tonnes 17-06-2020 View substance registered dossier
Isonicotinic acid
200-228-2 55-22-1 Active Full Joint ≥ 1 to < 10 tonnes 16-02-2018 View substance registered dossier
Isonicotinic acid
200-228-2 55-22-1 Active Intermediate Joint Intermediate use only 13-12-2019 View substance registered dossier
Bis(4-hydroxy-N-methylanilinium) sulphate
200-237-1 55-55-0 Cease Manufacture Full Joint Cease manufacture 31-03-2018 View substance registered dossier
Chlorhexidine
200-238-7 55-56-1 Active Intermediate Joint Intermediate use only 24-05-2013 View substance registered dossier
Glycerol trinitrate
200-240-8 55-63-0 Active Full Joint ≥ 1 000 to < 10 000 tonnes 31-01-2022 View substance registered dossier
p-methoxyphenethylamine
200-245-5 55-81-2 Active Intermediate Joint Intermediate use only 30-10-2018 View substance registered dossier
Methylthiouracil
200-252-3 56-04-2 Active Full Joint ≥ 1 to < 10 tonnes 03-11-2022 View substance registered dossier
2,6-diamino-1H-pyrimidin-4-one
200-254-4 56-06-4 Active Intermediate Individual Intermediate use only 15-01-2016 View substance registered dossier
4-aminobutyric acid
200-258-6 56-12-2 Active Full Joint ≥ 10 to < 100 tonnes 14-04-2023 View substance registered dossier
3,3'-iminodi(propylamine)
200-261-2 56-18-8 Active Full Joint ≥ 100 to < 1 000 tonnes 20-01-2020 View substance registered dossier
Carbon tetrachloride
200-262-8 56-23-5 Active Full Joint ≥ 1 000 to < 10 000 tonnes 02-02-2023 View substance registered dossier
Tetraethylammonium chloride
200-267-5 56-34-8 Active Full Joint ≥ 1 to < 10 tonnes 06-07-2022 View substance registered dossier
Bis(tributyltin) oxide 200-268-0 56-35-9 Active Intermediate Joint Intermediate use only 03-07-2020 View substance registered dossier
Benzyltriethylammonium chloride
200-270-1 56-37-1 Active Full Joint ≥ 100 to < 1 000 tonnes 06-10-2022 View substance registered dossier
Benzyltriethylammonium chloride
200-270-1 56-37-1 Active Intermediate Joint Intermediate use only 29-01-2020 View substance registered dossier
Glycine
200-272-2 56-40-6 Active Full Joint ≥ 1 000 to < 10 000 tonnes 23-03-2023 View substance registered dossier
L-alanine
200-273-8 56-41-7 Active Full Joint ≥ 1 000 to < 10 000 tonnes 27-04-2023 View substance registered dossier
L-serine
200-274-3 56-45-1 Active Full Joint ≥ 100 to < 1 000 tonnes 07-07-2022 View substance registered dossier
Quinidine
200-279-0 56-54-2 Active Full Joint ≥ 1 to < 10 tonnes 26-08-2020 View substance registered dossier
Chloramphenicol
200-287-4 56-75-7 Active Intermediate Joint Intermediate use only 30-05-2018 View substance registered dossier
Glycerol
200-289-5 56-81-5 Active Full Joint ≥ 1 000 to < 10 000 tonnes 18-04-2023 View substance registered dossier
Aspartic acid
200-291-6 56-84-8 Active Full Joint ≥ 1 000 to < 10 000 tonnes 26-04-2022 View substance registered dossier
Aspartic acid
200-291-6 56-84-8 Cease Manufacture Intermediate Individual Cease manufacture 03-04-2012 View substance registered dossier
Levoglutamide
200-292-1 56-85-9 Active Full Joint ≥ 100 to < 1 000 tonnes 14-06-2022 View substance registered dossier
Glutamic acid
200-293-7 56-86-0 Active Full Joint ≥ 100 to < 1 000 tonnes 31-03-2023 View substance registered dossier
Glutamic acid
200-293-7 56-86-0 Active Intermediate Joint Intermediate use only 28-01-2020 View substance registered dossier
Glutamic acid
200-293-7 56-86-0 Active Intermediate Individual Intermediate use only 19-12-2013 View substance registered dossier
Cystine
200-296-3 56-89-3 Active Full Joint ≥ 10 to < 100 tonnes 13-09-2022 View substance registered dossier
Cystine
200-296-3 56-89-3 Active Intermediate Joint Intermediate use only 06-02-2017 View substance registered dossier
2-imidazol-4-ylethylamine dihydrochloride
200-298-4 56-92-8 Active Intermediate Joint Intermediate use only 31-03-2023 View substance registered dossier
Benzyltrimethylammonium chloride
200-300-3 56-93-9 Active Full Joint ≥ 100 to < 1 000 tonnes 08-06-2016 View substance registered dossier
N-amidinosarcosine
200-306-6 57-00-1 Active Full Joint ≥ 10 to < 100 tonnes 11-10-2022 View substance registered dossier
Allyl isothiocyanate
200-309-2 57-06-7 Active Full Joint ≥ 100 to < 1 000 tonnes 22-02-2022 View substance registered dossier
Acexamic acid
200-310-8 57-08-9 Active Intermediate Joint Intermediate use only 07-02-2022 View substance registered dossier
Cetrimonium bromide
200-311-3 57-09-0 Active Full Joint ≥ 10 to < 100 tonnes 30-09-2021 View substance registered dossier
Palmitic acid
200-312-9 57-10-3 Active Full Joint ≥ 10 000 to < 100 000 tonnes 08-03-2023 View substance registered dossier
Stearic acid
200-313-4 57-11-4 Active Full Joint ≥ 10 000 to < 100 000 tonnes 08-03-2023 View substance registered dossier
Stearic acid
200-313-4 57-11-4 Cease Manufacture Intermediate Joint Cease manufacture 03-04-2018 View substance registered dossier
Urea
200-315-5 57-13-6 Active Full Joint ≥ 10 000 000 tonnes 05-05-2023 View substance registered dossier
N,N-dimethylhydrazine
200-316-0 57-14-7 Active Full Joint ≥ 1 to < 10 tonnes 12-12-2018 View substance registered dossier
Chlorbutanol
200-317-6 57-15-8 Active Full Joint ≥ 1 to < 10 tonnes 24-04-2019 View substance registered dossier
Morphine
200-320-2 57-27-2 Active Intermediate Joint Intermediate use only 20-03-2023 View substance registered dossier
Phenytoin
200-328-6 57-41-0 Active Intermediate Joint Intermediate use only 30-05-2018 View substance registered dossier
Pethidine
200-329-1 57-42-1 Active Intermediate Joint Intermediate use only 16-05-2018 View substance registered dossier
Barbital
200-331-2 57-44-3 Active Intermediate Joint Intermediate use only 26-05-2016 View substance registered dossier
Propane-1,2-diol
200-338-0 57-55-6 Active Full Joint ≥ 100 000 tonnes 12-05-2023 View substance registered dossier
Propiolactone
200-340-1 57-57-8 Active Full Joint ≥ 1 to < 10 tonnes 01-07-2022 View substance registered dossier
Sulfaguanidine
200-345-9 57-67-0 Active Intermediate Joint Intermediate use only 26-03-2018 View substance registered dossier
Sulfadimidine
200-346-4 57-68-1 Active Intermediate Joint Intermediate use only 20-04-2020 View substance registered dossier
Progesterone
200-350-6 57-83-0 Cease Manufacture Intermediate Joint Cease manufacture 21-07-2010 View substance registered dossier
Ergosterol
200-352-7 57-87-4 Active Intermediate Joint Intermediate use only 27-09-2016 View substance registered dossier
Cholesterol
200-353-2 57-88-5 Active Full Joint ≥ 100 to < 1 000 tonnes 15-03-2023 View substance registered dossier
Caffeine
200-362-1 58-08-2 Active Full Joint ≥ 1 000 to < 10 000 tonnes 20-09-2022 View substance registered dossier
Testosterone
200-370-5 58-22-0 Active Full Joint ≥ 1 to < 10 tonnes 22-11-2022 View substance registered dossier
Testosterone
200-370-5 58-22-0 Active Intermediate Joint Intermediate use only 12-04-2021 View substance registered dossier
Chlordiazepoxide
200-371-0 58-25-3 Active Intermediate Joint Intermediate use only 18-03-2022 View substance registered dossier
Menadione
200-372-6 58-27-5 Active Full Joint ≥ 0 to < 10 tonnes 27-10-2020 View substance registered dossier
Desipramine hydrochloride
200-373-1 58-28-6 Active Intermediate Joint Intermediate use only 07-12-2017 View substance registered dossier
Theophylline
200-385-7 58-55-9 Active Full Joint ≥ 1 to < 10 tonnes 07-04-2023 View substance registered dossier
Theophylline
200-385-7 58-55-9 Cease Manufacture Intermediate Individual Cease manufacture 25-06-2014 View substance registered dossier
Pyridoxine hydrochloride
200-386-2 58-56-0 Active Full Joint ≥ 100 to < 1 000 tonnes 16-07-2020 View substance registered dossier
Adenosine
200-389-9 58-61-7 Active Full Joint ≥ 10 to < 100 tonnes 18-04-2023 View substance registered dossier
Inosine
200-390-4 58-63-9 Active Intermediate Joint Intermediate use only 30-05-2018 View substance registered dossier
Cefalotin sodium
200-394-6 58-71-9 Active Intermediate Joint Intermediate use only 22-03-2018 View substance registered dossier
Diphenhydramine
200-396-7 58-73-1 Active Intermediate Joint Intermediate use only 19-10-2017 View substance registered dossier
Papaverine
200-397-2 58-74-2 Active Intermediate Joint Intermediate use only 23-06-2016 View substance registered dossier
Xylose
200-400-7 58-86-6 Active Full Joint ≥ 100 to < 1 000 tonnes 11-02-2022 View substance registered dossier
Xylose
200-400-7 58-86-6 Active Intermediate Individual Intermediate use only 29-11-2010 View substance registered dossier
Uridine
200-407-5 58-96-8 Active Intermediate Joint Intermediate use only 12-10-2020 View substance registered dossier
α-tocopherol
200-412-2 59-02-9 Active Full Joint ≥ 10 to < 100 tonnes 13-11-2019 View substance registered dossier
Nikethamide
200-418-5 59-26-7 Active Intermediate Joint Intermediate use only 02-10-2019 View substance registered dossier
Folic acid
200-419-0 59-30-3 Active Full Joint ≥ 1 to < 10 tonnes 20-09-2019 View substance registered dossier
Folic acid
200-419-0 59-30-3 Active Intermediate Joint Intermediate use only 27-09-2017 View substance registered dossier
Chloropyramine
200-421-1 59-32-5 Active Intermediate Joint Intermediate use only 03-08-2016 View substance registered dossier
Mepyramine maleate
200-422-7 59-33-6 Active Intermediate Joint Intermediate use only 04-05-2018 View substance registered dossier
Phenylephrine
200-424-8 59-42-7 Cease Manufacture Intermediate Individual Cease manufacture 19-12-2012 View substance registered dossier
Phenylephrine
200-424-8 59-42-7 Active Intermediate Individual Intermediate use only 07-12-2012 View substance registered dossier
Chlorocresol
200-431-6 59-50-7 Active Full Joint ≥ 10 to < 100 tonnes 29-09-2021 View substance registered dossier
Nicotinic acid
200-441-0 59-67-6 Active Full Joint ≥ 100 to < 1 000 tonnes 25-07-2018 View substance registered dossier
Nicotinic acid
200-441-0 59-67-6 Active Intermediate Joint Intermediate use only 17-07-2018 View substance registered dossier
Levodopa
200-445-2 59-92-7 Active Intermediate Joint Intermediate use only 16-03-2020 View substance registered dossier
Edetic acid
200-449-4 60-00-4 Active Intermediate Individual Intermediate use only 25-02-2016 View substance registered dossier
Edetic acid
200-449-4 60-00-4 Active Full Joint ≥ 1 000 tonnes 14-04-2023 View substance registered dossier
4-aminoazobenzene
200-453-6 60-09-3 Active Intermediate Individual Intermediate use only 09-12-2015 View substance registered dossier
2-phenylethanol
200-456-2 60-12-8 Active Full Joint ≥ 1 000 to < 10 000 tonnes 08-06-2022 View substance registered dossier
2-phenylethanol
200-456-2 60-12-8 No longer Valid Full Individual No longer valid 04-10-2012 View substance registered dossier
2-phenylethanol
200-456-2 60-12-8 Cease Manufacture Intermediate Joint Cease manufacture 30-03-2021 View substance registered dossier
Tyrosine
200-460-4 60-18-4 Active Full Joint ≥ 1 to < 10 tonnes 31-08-2021 View substance registered dossier
4-hydroxyphenethylammonium chloride
200-462-5 60-19-5 Active Intermediate Joint Intermediate use only 21-06-2018 View substance registered dossier
Mercaptamine
200-463-0 60-23-1 Active Full Joint ≥ 0 to < 10 tonnes 17-05-2018 View substance registered dossier
2-mercaptoethanol
200-464-6 60-24-2 Active Full Joint ≥ 1 000 to < 10 000 tonnes 04-05-2022 View substance registered dossier
2-imino-1-methylimidazolidin-4-one
200-466-7 60-27-5 Active Full Joint ≥ 0 to < 10 tonnes 11-10-2022 View substance registered dossier
Diethyl ether
200-467-2 60-29-7 Active Full Joint ≥ 1 000 to < 10 000 tonnes 17-10-2022 View substance registered dossier
Aminocaproic acid
200-469-3 60-32-2 Active Full Joint ≥ 10 tonnes 24-10-2022 View substance registered dossier
Methylhydrazine
200-471-4 60-34-4 Active Full Joint ≥ 10 to < 100 tonnes 16-02-2018 View substance registered dossier
Methylhydrazine
200-471-4 60-34-4 Cease Manufacture Intermediate Individual Cease manufacture 15-11-2012 View substance registered dossier
Methylhydrazine
200-471-4 60-34-4 Active Intermediate Joint Intermediate use only 11-01-2017 View substance registered dossier
Methylhydrazine
200-471-4 60-34-4 Active Intermediate Individual Intermediate use only 22-03-2011 View substance registered dossier
Acetamide
200-473-5 60-35-5 Active Full Joint ≥ 10 to < 100 tonnes 26-04-2018 View substance registered dossier
Tetracycline
200-481-9 60-54-8 Active Intermediate Joint Intermediate use only 10-05-2016 View substance registered dossier
Thiamazole
200-482-4 60-56-0 Active Intermediate Joint Intermediate use only 15-12-2016 View substance registered dossier
Phenazone
200-486-6 60-80-0 Active Intermediate Joint Intermediate use only 01-04-2022 View substance registered dossier
2'-(β-D-glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone
200-487-1 60-81-1 Active Full Joint ≥ 1 to < 10 tonnes 13-11-2017 View substance registered dossier
Promethazine
200-489-2 60-87-7 Active Intermediate Joint Intermediate use only 17-03-2023 View substance registered dossier
Quinine dihydrochloride
200-493-4 60-93-5 Active Intermediate Joint Intermediate use only 06-03-2015 View substance registered dossier
Acepromazine
200-496-0 61-00-7 Active Intermediate Individual Intermediate use only 27-01-2015 View substance registered dossier
Adenosine phosphate
200-500-0 61-19-8 Active Full Joint ≥ 1 to < 10 tonnes 10-03-2022 View substance registered dossier
2-(indol-3-yl)ethylamine
200-510-5 61-54-1 Active Intermediate Joint Intermediate use only 29-09-2014 View substance registered dossier
Phenylephrine hydrochloride
200-517-3 61-76-7 Active Intermediate Joint Intermediate use only 18-06-2014 View substance registered dossier
Amitrole
200-521-5 61-82-5 Active Full Joint ≥ 1 to < 10 tonnes 15-12-2021 View substance registered dossier
L-leucine
200-522-0 61-90-5 Active Full Joint ≥ 10 to < 100 tonnes 07-04-2022 View substance registered dossier
4-nitrobenzoic acid
200-526-2 62-23-7 Active Full Joint ≥ 1 to < 10 tonnes 17-06-2019 View substance registered dossier
4-nitrobenzoic acid
200-526-2 62-23-7 Active Intermediate Joint Intermediate use only 24-01-2023 View substance registered dossier
4-nitrobenzoic acid
200-526-2 62-23-7 Active Intermediate Individual Intermediate use only 21-12-2012 View substance registered dossier
Sodium calcium edetate
200-529-9 62-33-9 Active Full Joint ≥ 1 000 to < 10 000 tonnes 16-12-2022 View substance registered dossier
Phenacetin
200-533-0 62-44-2 Active Full Joint ≥ 1 to < 10 tonnes 09-03-2023 View substance registered dossier
Choline
200-535-1 62-49-7 Active Intermediate Joint Intermediate use only 25-05-2018 View substance registered dossier
Aniline 200-539-3 62-53-3 Active Full Joint ≥ 1 000 000 to < 10 000 000 tonnes 13-10-2022 View substance registered dossier
Aniline 200-539-3 62-53-3 Cease Manufacture Intermediate Joint Cease manufacture 23-03-2018 View substance registered dossier
Calcium di(acetate)
200-540-9 62-54-4 Active Full Joint ≥ 1 000 tonnes 27-04-2023 View substance registered dossier
Thioacetamide
200-541-4 62-55-5 Active Intermediate Individual Intermediate use only 30-09-2010 View substance registered dossier
thiourea; thiocarbamide
200-543-5 62-56-6 Active Full Joint ≥ 1 000 to < 10 000 tonnes 26-04-2023 View substance registered dossier
2-amino-2-methylpropionic acid
200-544-0 62-57-7 Active Intermediate Joint Intermediate use only 21-11-2019 View substance registered dossier
Disodium oxalate
200-550-3 62-76-0 Active Full Joint ≥ 10 tonnes 23-08-2022 View substance registered dossier
Androst-4-ene-3,17-dione
200-554-5 63-05-8 Active Full Joint ≥ 10 to < 100 tonnes 15-11-2022 View substance registered dossier
Cytidine 3'-(dihydrogen phosphate)
200-556-6 63-37-6 Active Full Joint ≥ 10 to < 100 tonnes 07-02-2018 View substance registered dossier
L-methionine
200-562-9 63-68-3 Active Full Joint ≥ 10 to < 100 tonnes 29-07-2021 View substance registered dossier
Sulphanilamide
200-563-4 63-74-1 Active Intermediate Joint Intermediate use only 11-07-2019 View substance registered dossier
3-phenyl-L-alanine
200-568-1 63-91-2 Active Full Joint ≥ 10 to < 100 tonnes 01-06-2022 View substance registered dossier
3-phenyl-L-alanine
200-568-1 63-91-2 Active Intermediate Joint Intermediate use only 29-11-2021 View substance registered dossier
Tetrasodium ethylenediaminetetraacetate
200-573-9 64-02-8 Active Full Joint ≥ 10 000 to < 100 000 tonnes 26-04-2023 View substance registered dossier
Tetrasodium ethylenediaminetetraacetate
200-573-9 64-02-8 Active Intermediate Individual Intermediate use only 21-01-2015 View substance registered dossier
Phenethylamine
200-574-4 64-04-0 Active Intermediate Joint Intermediate use only 13-10-2022 View substance registered dossier
Ethanol
200-578-6 64-17-5 Active Full Joint ≥ 10 000 000 tonnes 17-05-2023 View substance registered dossier
Ethanol
200-578-6 64-17-5 No longer Valid Full Individual No longer valid 11-01-2016 View substance registered dossier
Formic acid
200-579-1 64-18-6 Active Full Joint ≥ 100 000 to < 1 000 000 tonnes 01-12-2022 View substance registered dossier
Formic acid
200-579-1 64-18-6 Active Intermediate Joint Intermediate use only 23-03-2018 View substance registered dossier
Acetic acid
200-580-7 64-19-7 Active Full Joint ≥ 1 000 000 tonnes 24-04-2023 View substance registered dossier
Diethyl sulphate
200-589-6 64-67-5 Active Full Joint ≥ 1 to < 10 tonnes 26-04-2018 View substance registered dossier
Diethyl sulphate
200-589-6 64-67-5 Active Intermediate Individual Intermediate use only 16-01-2015 View substance registered dossier
Diethyl sulphate
200-589-6 64-67-5 Active Intermediate Joint Intermediate use only 17-05-2023 View substance registered dossier
Demeclocycline hydrochloride
200-592-2 64-73-3 Active Intermediate Joint Intermediate use only 01-10-2018 View substance registered dossier
Tetracycline hydrochloride
200-593-8 64-75-5 Active Intermediate Joint Intermediate use only 01-10-2018 View substance registered dossier
Colchicine
200-598-5 64-86-8 Active Intermediate Individual Intermediate use only 29-09-2010 View substance registered dossier
Pyridoxine
200-603-0 65-23-6 Active Intermediate Joint Intermediate use only 28-05-2018 View substance registered dossier
Nicotine sulphate
200-606-7 65-30-5 Cease Manufacture Full Joint Cease manufacture 27-11-2020 View substance registered dossier
Nicotine dihydrogen ditartrate
200-607-2 65-31-6 Active Full Joint ≥ 10 to < 100 tonnes 21-12-2022 View substance registered dossier
Salicylamide
200-609-3 65-45-2 Active Intermediate Joint Intermediate use only 21-03-2023 View substance registered dossier
4-aminosalicylic acid
200-613-5 65-49-6 Active Intermediate Joint Intermediate use only 23-11-2022 View substance registered dossier
No results were found
Registrant/Supplier Address Country Registration Status Name EC / List no. CAS no. Last update year Details
CURIA SPAIN, S.A.U. Parque Tecnológico de Boecillo, parcela 105 47151 Boecillo Valladolid Spain Spain Active Dexamethasone 200-003-9 50-02-2 - View substance registered dossier
EUROAPI FRANCE 15 rue Traversière 75012 Paris France France Active Dexamethasone 200-003-9 50-02-2 2021; 2022 View substance registered dossier
[Confidential] - - - Hydrocortisone 21-acetate 200-004-4 50-03-3 - View substance registered dossier
Bayer AG Kaiser-Wilhelm-Allee 1 51373 Leverkusen Germany Germany Cease Manufacture Hydrocortisone 21-acetate 200-004-4 50-03-3 2012 View substance registered dossier
EUROAPI FRANCE 15 rue Traversière 75012 Paris France France Active Cortisone 21-acetate 200-006-5 50-04-4 2021; 2022 View substance registered dossier
Alkaloida Chemical Company Zrt. Kabay Janos 29 H-4440 Tiszavasvari Hungary Hungary Active Phenobarbital 200-007-0 50-06-6 - View substance registered dossier
SIGMA-ALDRICH CHEMIE GMBH Riedstrasse 2 89555 Steinheim Germany Germany Active Lactic acid 200-018-0 50-21-5 2021 View substance registered dossier
Sacco S.r.l. via Alessandro Manzoni 29a 22071 Cadorago Como Italy Italy Active Lactic acid 200-018-0 50-21-5 - View substance registered dossier
Chementors Oy Smart Chemistry Park Raisionkaari 55 21200 Raisio Finland Finland Active Lactic acid 200-018-0 50-21-5 2021 View substance registered dossier
Purac Biochem bv Arkelsedijk 46 4206AC Gorinchem Netherlands Netherlands Active Lactic acid 200-018-0 50-21-5 2018; 2021; 2022 View substance registered dossier
Galactic Place d'Escanaffles 23 7760 Escanaffles Belgium Belgium Active Lactic acid 200-018-0 50-21-5 2022 View substance registered dossier
BIOFER SpA Via Tommaso da Cazzaniga 9/6 20121 Milano Milano Italy Italy Active Hydrocortisone 200-020-1 50-23-7 2012; 2013; 2021 View substance registered dossier
NEWCHEM S.P.A. VIA EDMONDO DE AMICIS 47 20123 MILANO ITALY Italy Italy Active Hydrocortisone 200-020-1 50-23-7 2013 View substance registered dossier
RSI ChemRep Europe Ltd (P001) 27-30 Merchants Quay Merchants House 8 Dublin Ireland Ireland Active Hydrocortisone 200-020-1 50-23-7 2021; 2022 View substance registered dossier
[Confidential] - - - Hydrocortisone 200-020-1 50-23-7 - View substance registered dossier
VALDEPHARM Parc Industriel d'Incarville CS10606 27106 Val de Reuil France France Active Hydrocortisone 200-020-1 50-23-7 2012 View substance registered dossier
Farmabios Spa Via Pavia, 1 27027 Gropello Cairoli PV Italy Italy Active Hydrocortisone 200-020-1 50-23-7 - View substance registered dossier
Bayer AG Kaiser-Wilhelm-Allee 1 51373 Leverkusen Germany Germany Cease Manufacture Hydrocortisone 200-020-1 50-23-7 2015 View substance registered dossier
ZaCh System ZI La Croix Cadeaux 49242 Avrillè France France Active Prednisolone 200-021-7 50-24-8 - View substance registered dossier
CURIA SPAIN, S.A.U. Parque Tecnológico de Boecillo, parcela 105 47151 Boecillo Valladolid Spain Spain Active Prednisolone 200-021-7 50-24-8 - View substance registered dossier
Farmabios Spa Via Pavia, 1 27027 Gropello Cairoli PV Italy Italy Active Prednisolone 200-021-7 50-24-8 2011 View substance registered dossier
[Confidential] - - - Prednisolone 200-021-7 50-24-8 - View substance registered dossier
Steroid SpA Viale Spagna 156 20093 Cologno Monzese Milano Italy Italy Active Prednisolone 200-021-7 50-24-8 - View substance registered dossier
Aspen Oss BV Kloosterstraat 6 5349 AB Oss Netherlands Netherlands Cease Manufacture Prednisolone 200-021-7 50-24-8 2022 View substance registered dossier
NEWCHEM S.P.A. VIA EDMONDO DE AMICIS 47 20123 MILANO ITALY Italy Italy Active Prednisolone 200-021-7 50-24-8 2013 View substance registered dossier
Bayer AG Kaiser-Wilhelm-Allee 1 51373 Leverkusen Germany Germany Active Estradiol 200-023-8 50-28-2 2012; 2017; 2021 View substance registered dossier
VALDEPHARM Parc Industriel d'Incarville CS10606 27106 Val de Reuil France France Active Estradiol 200-023-8 50-28-2 2012; 2018 View substance registered dossier
Gedeon Richter Plc. Gyomroi ut 19-21 1103 Budapest Hungary Hungary Active 2,3-dichlorobenzoic acid 200-039-5 50-45-3 2020 View substance registered dossier
Lundbeck Pharmaceuticals Italy S.p.A via quarta strada 2 35129 padova Italy Italy Active Desipramine 200-040-0 50-47-5 - View substance registered dossier
OLON Spa Strada Rivoltana Km 6/7 20053 RODANO Milano Italy Italy Cease Manufacture Amitriptyline 200-041-6 50-48-6 2022 View substance registered dossier
Global Product Compliance (Europe) AB IDEON, Beta 5, Scheelevägen 17 223 63 Lund Sweden Sweden Active Amitriptyline 200-041-6 50-48-6 - View substance registered dossier
Sigma-Aldrich Ireland Ltd Vale Road . Arklow Co. Wicklow Ireland Ireland Active Amitriptyline 200-041-6 50-48-6 - View substance registered dossier
Lundbeck Pharmaceuticals Italy S.p.A via quarta strada 2 35129 padova Italy Italy Active Imipramine 200-042-1 50-49-7 - View substance registered dossier
Corden Pharma Bergamo S.p.A. Via Bergamo, 121 IT-24047 Treviglio BG Italy Italy Active Imipramine 200-042-1 50-49-7 - View substance registered dossier
PCAS Finland Oy Messukentänkatu 8 20210 TURKU Finland Finland Active Imipramine 200-042-1 50-49-7 - View substance registered dossier
Trifarma S.p.A. Via G. Guarini Matteucci 1 20162 Milan (MI) Italy Italy Active Thioridazine 200-044-2 50-52-2 - View substance registered dossier
sanofi chimie 82 avenue Raspail 94250 Gentilly France France Active Chlorpromazine 200-045-8 50-53-3 - View substance registered dossier
LUCAS MEYER COSMETICS 13 rue Ella Maillart Campus Eiffel - Bâtiment Edison 91300 MASSY Ile-De-France France France Active D-ribose 200-059-4 50-69-1 2019 View substance registered dossier
F.I.S. Fabbrica Italiana Sintetici S.p.a. Viale Milano, 26 36075 Montecchio Maggiore (VI) Veneto Italy Italy Active D-ribose 200-059-4 50-69-1 - View substance registered dossier
SONEAS Chemicals Ltd. Banyaleg Str. 47-59. H-1225 Budapest Hungary Hungary Active D-ribose 200-059-4 50-69-1 - View substance registered dossier
Gilead Sciences Ireland UC IDA Business &Technology Park Carrigtohill Cork Cork Ireland Ireland Active D-ribose 200-059-4 50-69-1 - View substance registered dossier
Esteve Quimica, S.A. Torre Esteve Passeig de la Zona Franca, 109, 4ª Planta 08038 Barcelona Barcelona Spain Spain Active D-ribose 200-059-4 50-69-1 - View substance registered dossier
QUIMDIS SAS 71, rue Anatole France 92532 Levallois-Perret France France Active D-ribose 200-059-4 50-69-1 - View substance registered dossier
NOVACYL SAS 21 chemin de la Sauvegarde « 21 Ecully Parc » - CS 33167 69134 ECULLY CEDEX France France Active O-acetylsalicylic acid 200-064-1 50-78-2 - View substance registered dossier
Sanofi Winthrop Industrie 20, avenue Raymond Aron 92165 Antony Cedex France France Active O-acetylsalicylic acid 200-064-1 50-78-2 2015 View substance registered dossier
Global Product Compliance (Europe) AB IDEON, Beta 5, Scheelevägen 17 22363 Lund Sweden Sweden No longer Valid 2-hydroxy-p-toluic acid 200-068-3 50-85-1 2021 View substance registered dossier
Global Product Compliance (Europe) AB IDEON, Beta 5, Scheelevägen 17 223 63 Lund Sweden Sweden Active 2-hydroxy-p-toluic acid 200-068-3 50-85-1 - View substance registered dossier
Zach System ZI La Croix Cadeau 49242 Avrillé France France Active 2-hydroxy-p-toluic acid 200-068-3 50-85-1 2021 View substance registered dossier
[Confidential] - - - Thymidine 200-070-4 50-89-5 - View substance registered dossier
Nalco Europe B.V. Oude Rhijnhofweg 17 2342 BB Oegstgeest Netherlands Netherlands Active α-phenyl-1H-benzimidazole-2-methanol 200-073-0 50-97-5 2022 View substance registered dossier
Aceto France SAS 3 Rue de Genève CS 50363 BP 50367 Lyon Cedex 06 France France Active Ephedrine hydrochloride 200-074-6 50-98-6 - View substance registered dossier
Siegfried PharmaChemikalien Minden GmbH Karlstr. 15-39, 42-44 32423 Minden Nordrhein-Westphalen Germany Germany Active Ephedrine hydrochloride 200-074-6 50-98-6 2018 View substance registered dossier
ENDURA S.p.A. Viale Pietramellara, 5 40121 Bologna Italy Italy Active 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether 200-076-7 51-03-6 2014; 2020; 2022 View substance registered dossier
Copyr S.p.A. Via G. Stephenson 73 20157 Milano Italy Italy No longer Valid